Co-expression of CdtA and CdtC subunits of cytolethal distending toxin from Aggregatibacter actinomycetemcomitans
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Cytolethal distending toxin (CDT) is a family of heat-labile cytotoxins produced by several gram-negative mucosa-associated pathogens, including Aggregatibacter actinomycetemcomitans. CDT is well known to be capable of inducing growth arrest, morphological alterations, and eventually death in various cells. CDT belongs to a tripartite AB₂ toxin (CdtB: the enzymatic A subunit; CdtA and CdtC: the heterodimeric B subunit). Previous studies proposed that CdtA and CdtC together bind to a cell surface receptor and glycolipids act as a receptor for A. actinomycetemcomitans CDT (AaCDT). In this study, recombinant CdtA and CdtC proteins of AaCDT were co-expressed in a bacterial expression system and tested for their affinity for GM₁ ganglioside. Methods: The genes for CdtA and CdtC from A. actinomycetemcomitans Y4 were utilized to construct the expression vectors, pRSET-cdtA and pET28a-cdtC. Both CdtA and CdtC proteins were expressed in Escherichia coli BL21(DE3) and then purified using hexahistidine (His6) tag. The identity of purified protein was confirmed by anti-His6 antibody and monoclonal anti-CdtA antibody. Furthermore, the affinity of recombinant protein to GM₁ ganglioside was checked through ELISA. Results: Recombinant CdtA and CdtC proteins were expressed as soluble proteins and reacted to anti-His6 and monoclonal anti-CdtA antibodies. ELISA revealed that purified soluble CdtA-CdtC protein bound to GM₁ ganglioside, while CdtA alone did not. Conclusions: Co-expression of CdtA and CdtC proteins enhanced the solubility of the proteins in E. coli, leading to convenient preparation of active CdtA-CdtC, a critical material for the study of AaCDT pathogenesis. (J Korean Acad Periodontol 2009;39:231-237)
Abstract
Purpose: Cytolethal distending toxin (CDT) is a family of heat-labile cytotoxins produced by several gram-negative mucosa-associated pathogens, including Aggregatibacter actinomycetemcomitans. CDT is well known to be capable of inducing growth arrest, morphological alterations, and eventually death in various cells. CDT belongs to a tripartite AB₂ toxin (CdtB: the enzymatic A subunit; CdtA and CdtC: the heterodimeric B subunit). Previous studies proposed that CdtA and CdtC together bind to a cell surface receptor and glycolipids act as a receptor for A. actinomycetemcomitans CDT (AaCDT). In this study, recombinant CdtA and CdtC proteins of AaCDT were co-expressed in a bacterial expression system and tested for their affinity for GM₁ ganglioside. Methods: The genes for CdtA and CdtC from A. actinomycetemcomitans Y4 were utilized to construct the expression vectors, pRSET-cdtA and pET28a-cdtC. Both CdtA and CdtC proteins were expressed in Escherichia coli BL21(DE3) and then purified using hexahistidine (His6) tag. The identity of purified protein was confirmed by anti-His6 antibody and monoclonal anti-CdtA antibody. Furthermore, the affinity of recombinant protein to GM₁ ganglioside was checked through ELISA. Results: Recombinant CdtA and CdtC proteins were expressed as soluble proteins and reacted to anti-His6 and monoclonal anti-CdtA antibodies. ELISA revealed that purified soluble CdtA-CdtC protein bound to GM₁ ganglioside, while CdtA alone did not. Conclusions: Co-expression of CdtA and CdtC proteins enhanced the solubility of the proteins in E. coli, leading to convenient preparation of active CdtA-CdtC, a critical material for the study of AaCDT pathogenesis. (J Korean Acad Periodontol 2009;39:231-237)
참고문헌 (28)
- Henderson B, "Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans", Annu Rev Microbiol, 57, pp.29~55 (2003)
- Lara-Tejero M, "Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions", Trends Microbiol, 10, pp.147~152 (2002)
- Leung WK, "Characterization of Actinobacillus actinomycetemcomitans isolated from young Chinese aggressive periodontitis patients", J Periodontal Res, 40, pp.258~268 (2005)
- Ahmed HJ, "Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains", J Med Microbiol, 50, pp.860~864 (2001)
- Fabris AS, "Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitansisolates from geographically diverse populations", Oral Microbiol Immunol, 17, pp.231~238 (2002)
- Belibasakis G, "Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin", Eur J Oral Sci, 110, pp.366~373 (2002)
- Kanno F, "Resistance of human periodontal ligament fibroblasts to the cytolethal distending toxin of Actinobacillus actinomycetemcomitans", J Periodontol, 76, pp.1189~1201 (2005)
- DiRienzo JM, "Kinetics of KB and HEp-2 cell responses to an invasive, cytolethal distending toxin producing strain of Actinobacillus actinomycetemcomitans", Oral Microbiol Immunol, 17, pp.245~251 (2002)
- Belibasakis GN, "The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells", Infect Immun, 73, pp.342~351 (2005)
- Belibasakis GN, "Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells", APMIS, 116, pp.499~506 (2008)
- Mogi M, "Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis", J Dent Res, 83, pp.166~169 (2004)
- Pickett CL, "Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes", Infect Immun, 62, pp.1046~1051 (1994)
- Elwell CA, "DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest", Mol Microbiol, 37, pp.952~963 (2000)
- Nesic D, "Assembly and function of a bacterial genotoxin", Nature, 429, pp.429~433 (2004)
- Peres SY, "A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2", M phase, 1997, pp.24, 1095~1107
- Lee RB, "Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells", Infect Immun, 71, pp.4883~4890 (2003)
- McSweeney LA, "Carbohydrate-binding specif icity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits", Infect Immun, 73, pp.2051~2060 (2005)
- Mise K, "Involvement of ganglioside GM3 in G2", M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin, 2005, pp.73, 4846~4852
- Yamada T, "Variation of loop sequence alters stability of cytolethal distending toxin (CDT): crystal structure of CDT from Actinobacillus actinomycetemcomitans", Protein Sci, 15, pp.362~372 (2006)
- Boesze-Battaglia K, "Cholesterolrich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal- distending toxin", Cell Microbiol, 8, pp.823~836 (2006)
- Saiki K, "Reconstitution and purification of cytolethal distending toxin of Actinobacillus actinomycetemcomitans", Microbiol Immunol, 45, pp.497~506 (2001)
- 고선영, "Actinobacillus actinomycetemcomitans의 cytolethal distending toxin subunit CdtA 유전자 클로닝과 단백질 발현", The Journal of the Korean Academy of Periodontology (JPIS), 37(5), pp.339~351 (2007), 대한치주과학회
- 이은선, "Cloning and protein expression of Aggregatibacter actinomycetemcomitans cytolethal distending toxin C", The Journal of the Korean Academy of Periodontology (JPIS), 38(2), pp.317~324 (2008), 대한치주과학회
- Mao X, "Functional studies of the recombinant subunits of a cytolethal distending holotoxin", Cell Microbiol, 4, pp.245~255 (2002)
- Nesic D, "Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT", PLoS Pathog, 1, pp.214~224 (2005)
- Ueno Y, "Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin", Infect Immun, 74, pp.3480~3487 (2006)
- Lagergard T, "Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin", Vaccine, 25, pp.3606~3614 (2007)
- Mbwana J, "Specificity of antibodies directed against the cytolethal distending toxin of Haemophilus ducreyi in patients with chancroid", Microb Pathog, 35, pp.133~137 (2003)